Therapeutic potential of ayahuasca in grief: a prospective, observational study
Open accessThe DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
Rationale: Recent studies have assessed the therapeutic potential of ayahuasca for the treatment of depression with promising preliminary results . Objectives: Here, we examine the course of grief over 1 year of follow-up in a bereaved sample that attended a center in Peru to participate in indigenous Shipibo ayahuasca ceremonies. We also explore the roles of experiential avoidance and decentering as mechanisms of change. Methods: Bereaved participants who attended the ayahuasca center responded to an online survey that included the Texas Revised Inventory of Grief, Symptom Assessment-45, WHO Quality of Life-Bref, Acceptance and Action Questionnaire, and Decentering. Baseline assessment was completed by 50 individuals (T0). Of these, 39 completed the post-assessment at 15 days (T1), 31 at 3 months (T2), 29 at 6 months (T3), and 27 at 12 months (T4) after leaving the retreat. Pearson’s analysis was performed to examine the relationship between the severity of grief and mechanisms of change during the period of T0 and T1. Results: A significant decrease in Texas Revised Inventory was observed at all time points (T1: Cohen’s d = 0.84; T2: Cohen’s d = 1.38; T3: Cohen’s d = 1.16; T4: Cohen’s d = 1.39). We found a relationship between experiential avoidance ( r = 0.55; p < .01), decentering ( r = − 0.47; p < .01), and a reduction in the severity of grief. Conclusions: Our results suggest that the ceremonial use of ayahuasca has therapeutic value by reducing the severity of grief. Acceptance and decentering are both psychological processes that mediate the improvement of grief symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ayahuasca has been demonstrated to be safe in naturalistic (35, 108) and clinical settings, across varying dosages and multiple administrations (26, 109–112).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Previous observational research, however, has suggested that the ceremonial use of ayahuasca has therapeutic value in reducing the severity of grief (34–36).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment
THE WHOQOL GROUP (1998) · Psychological Medicine · doi:10.1017/s0033291798006667 · Cited by 7,933
Skevington, S. M., Lotfy, M., & O'Connell, K. A. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018486.91360.00 · Cited by 4,686
Bond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., Waltz, T., & Zettle, R. D. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.007 · Cited by 3,950
Prolonged grief disorder: psychometric validation of criteria proposed for DSM-V and ICD-11
Prigerson, H. G., Horowitz, M. J., Jacobs, S. C., Parkes, C. M., Aslan, M., Goodkin, K., Raphael, B., Marwit, S. J., Wortman, C., Neimeyer, R. A., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000121 · Cited by 1,863 · cited 2×
“…or shocked, emotional numbness, mistrust of others, bitterness over the loss, confusion about one’s role in life, a diminished sense of self, difficulty accepting the loss, and moving on with life are normal reactions when bereaved in the aftermath of a death of a love one (Prigerson et al. 2009).”
BackgroundPrevalence of prolonged grief disorder in adult bereavement: A systematic review and meta-analysis
Lundorff, M., Holmgren, H., Zachariae, R., Farver-Vestergaard, I., & O’Connor, M. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.01.030 · Cited by 876 · cited 1×
“Prolonged Grief Disorder (PGD) has recently been included in the latest version of the International Classification of Disease (ICD-11) (World Health Organization, 2018), with an estimated prevalence of 9.8% among bereaved individuals (Lundorff et al. 2017).”
BackgroundInfluentialPalhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852
Fresco, D. M., Moore, M. T., van Dulmen, M. H. M., Segal, Z. V., Ma, S. H., Teasdale, J. D., & Williams, J. M. G. (2007) · Behavior Therapy · doi:10.1016/j.beth.2006.08.003 · Cited by 810
Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11
Maercker, A., Brewin, C. R., Bryant, R. A., Cloitre, M., van Ommeren, M., Jones, L. M., Humayan, A., Kagee, A., Llosa, A. E., Rousseau, C., et al. (2013) · World Psychiatry · doi:10.1002/wps.20057 · Cited by 762
The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488
Sanches, R. F., de Lima Osório, F., dos Santos, R. G., Macedo, L. R. H., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000436 · Cited by 466
Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers
Hofmann, A., & Schultes, R. E. (1992) · Medical Entomology and Zoology · Cited by 463
Boelen, P. A., de Keijser, J., van den Hout, M. A., & van den Bout, J. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.2.277 · Cited by 454 · cited 1×
“Studies that have obtained higher effects sizes have applied specific protocols of intervention, which involved conducting from 12 to 25 psychotherapeutic sessions during periods of 3 to 9 months, or even longer (Bryant et al., 2014; Rosner et al. 2014; Boelen et al. 2007).”
BackgroundPalhano-Fontes, F., Andrade, K. C., Tofoli, L. F., Santos, A. C., Crippa, J. A. S., Hallak, J. E. C., Ribeiro, S., & de Araujo, D. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118143 · Cited by 454
Grief and bereavement: what psychiatrists need to know
ZISOOK, S., & SHEAR, K. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00217.x · Cited by 451
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390
The prevention and treatment of complicated grief: a meta-analysis
Wittouck, C., Van Autreve, S., De Jaegere, E., Portzky, G., & van Heeringen, K. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.09.005 · Cited by 361
Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial
Shear, M. K., Reynolds, C. F., Simon, N. M., Zisook, S., Wang, Y., Mauro, C., Duan, N., Lebowitz, B., & Skritskaya, N. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0892 · Cited by 349
Bouso, J. C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Ribeiro Barbosa, P. C., Alcázar-Córcoles, M. Á., Araújo, W. S., Barbanoj, M. J., Fábregas, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042421 · Cited by 313
Self-citationRiba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303
Boelen, P. A., & Prigerson, H. G. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0744-0 · Cited by 288
Religion and spirituality in adjustment following bereavement: an integrative review.
Wortmann, J. H., & Park, C. L. (2008) · Death Studies · doi:10.1080/07481180802289507 · Cited by 267
Efficacy of Virtual Reality Exposure Therapy in the Treatment of PTSD: A Systematic Review
Gonçalves, R., Pedrozo, A. L., Coutinho, E. S. F., Figueira, I., & Ventura, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048469 · Cited by 262
Treating Prolonged Grief Disorder: A Randomized Clinical Trial
Bryant, R. A., Kenny, L., Joscelyne, A., Rawson, N., Maccallum, F., Cahill, C., Hopwood, S., Aderka, I., & Nickerson, A. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1600 · Cited by 253
Meaning reconstruction in bereavement: Development of a research program
Neimeyer, R. A. (2019) · Death Studies · doi:10.1080/07481187.2018.1456620 · Cited by 242 · cited 1×
“Accommodation provides an opportunity for constructive processing and meaning making regarding the experience (Neimeyer 2019).”
BackgroundProlonged grief disorder: Diagnostic, assessment, and treatment considerations.
Jordan, A. H., & Litz, B. T. (2014) · Professional Psychology: Research and Practice · doi:10.1037/a0036836 · Cited by 234
Assessment of addiction severity among ritual users of ayahuasca.
Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.024 · Cited by 227
Self-citationAyahuasca: pharmacology, neuroscience and therapeutic potential
Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.002 · Cited by 226
Self-citationBouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., & Riba, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.008 · Cited by 218 · cited 1×
“Regular ayahuasca ceremony participants have performed well on neuropsychological tests (Bouso et al. 2012, 2015) and show low levels of psychopathological symptoms (Bouso et al. 2012, 2015; Barbosa et al. 2009).”
BackgroundSelf-citationSoler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4162-0 · Cited by 209
Self-citationSantos, R. G., Landeira-Fernandez, J., Strassman, R. J., Motta, V., & Cruz, A. P. M. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.04.012 · Cited by 205
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
Kuypers, K. P. C., Riba, J., de la Fuente Revenga, M., Barker, S., Theunissen, E. L., & Ramaekers, J. G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4377-8 · Cited by 201
Sampedro, F., de la Fuente Revenga, M., Valle, M., Roberto, N., Domínguez-Clavé, E., Elices, M., Luna, L. E., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx036 · Cited by 200
Self-citationEffects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00134 · Cited by 171
Davison, M. L., Bershadsky, B., Bieber, J., Silversmith, D., Maruish, M. E., & Kane, R. L. (1997) · Assessment · doi:10.1177/107319119700400306 · Cited by 143 · cited 6×
“In our sample, almost all the scales in SA-45 were above the score of 60 at baseline (percentile of 84) (Davison et al. 1997) suggesting likely problems with somatization, depression, obsessive-compulsiveness, anxiety, interpersonal sensitivity, phobic anxiety, and psychoticism.”
BackgroundInfluentialPharmacology of ayahuasca administered in two repeated doses
dos Santos, R. G., Grasa, E., Valle, M., Ballester, M. R., Bouso, J. C., Nomdedéu, J. F., Homs, R., Barbanoj, M. J., & Riba, J. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2434-x · Cited by 141
Self-citationRosner, R., Pfoh, G., Kotoučová, M., & Hagl, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.035 · Cited by 133
dos Santos, R. G., Balthazar, F. M., Bouso, J. C., & Hallak, J. E. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116652578 · Cited by 125
Self-citationBarbosa, P. C. R., Cazorla, I. M., Giglio, J. S., & Strassman, R. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10400530 · Cited by 108
Galvão, A. C. D. M., de Almeida, R. N., Silva, E. A. D. S., Freire, F. A. M., Palhano-Fontes, F., Onias, H., Arcoverde, E., Maia-de-Oliveira, J. P., de Araújo, D. B., Lobão-Soares, B., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00185 · Cited by 108
Soler, J., Elices, M., Dominguez-Clavé, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., García-Campayo, J., & Riba, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00224 · Cited by 102
Self-citationExperiences of encounters with Ayahuasca–“the vine of the soul”
Kjellgren, A., Eriksson, A., & Norlander, T. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10399767 · Cited by 97
Domínguez‐Clavé, E., Soler, J., Pascual, J. C., Elices, M., Franquesa, A., Valle, M., Álvarez, E., & Riba, J. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5085-3 · Cited by 94
Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology
Guimarães dos Santos, R. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.763564 · Cited by 87
Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach
Franquesa, A., Sainz-Cort, A., Gandy, S., Soler, J., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.012 · Cited by 58
Self-citationMeister, R., von Wolff, A., Mohr, H., Härter, M., Nestoriuc, Y., Hölzel, L., & Kriston, L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153380 · Cited by 50
Hayes, A. M., Yasinski, C. W., Grasso, D. J., Ready, C. B., Alpert, E., McCauley, T. G., Webb, C. P. M., & Deblinger, E. (2016) · Behavior Therapy · doi:10.1016/j.beth.2016.06.004 · Cited by 46
Acute effects of ayahuasca in a juvenile non-human primate model of depression
da Silva, F. S., Silva, E. A. S., Sousa Jr., G. M. D., Maia-de-Oliveira, J. P., Soares-Rachetti, V. D. P., de Araujo, D. B., Sousa, M. B. C., Lobão-Soares, B., Hallak, J., & Galvão-Coelho, N. L. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2018-0140 · Cited by 46
Potential use of ayahuasca in grief therapy
González, D., Carvalho, M., Cantillo, J., Aixalá, M., & Farré, M. (2019) · OMEGA - Journal of Death and Dying · doi:10.1177/0030222817710879 · Cited by 44
Self-citationThe role of religion in bereavement.
Hays, J. C., & Hendrix, C. C. (2008) · American Psychological Association eBooks · doi:10.1037/14498-016 · Cited by 43
Sacred Vine of Spirits: Ayahuasca
Metzner, R. (2005) · Cited by 40
Reliability and Validity of the SA-45: Further Evidence from a Primary Care Setting
Maruish, M. E., Bershadsky, B., & Goldstein, L. (1998) · Assessment · doi:10.1177/107319119800500410 · Cited by 36
Mediators of outcome in complicated grief treatment
Glickman, K., Shear, M. K., & Wall, M. M. (2017) · Journal of Clinical Psychology · doi:10.1002/jclp.22384 · Cited by 34
Chinese Immigrant Wealth: Heterogeneity in Adaptation
Keister, L. A., Vallejo, J. A., & Aronson, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168043 · Cited by 23
Wenn, J., O'Connor, M., Breen, L. J., Kane, R. T., & Rees, C. S. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007221 · Cited by 18
Cohen, I. M., Fischer, J. F., & Vogel, W. H. (1974) · Psychopharmacology · doi:10.1007/bf00441384 · Cited by 13
Research works printed but not linked: 3
- Cohen J Statistical power analyses for the social sciences 1988 New York Hills- dale, NJ: Lawrence Erlbaum
- Faschingbauer TR The Texas revised inventory of grief manual 1981 Houston Honeycomb
- Hayes SC Jacobson N A contextual approach to therapeutic change Psychotherapists in clinical practice: cognitive and behavioural perspectives 1987 New York Guilford Press 327 387
Cited by
Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey
Bouso, J. C., Andión, Ó., Sarris, J. J., Scheidegger, M., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000438 · Cited by 118
“Biomedical scientists are now interested in finding clinical applications for ayahuasca, having found improvements in clinical and non-clinical conditions like affective disorders [12–16], drug dependence [17, 18], emotional regulation in personality disorders [19], grief [20, 21], mindfulness and psychological flexib…”
BackgroundSelf-citationKiraga, M. K., Mason, N. L., Uthaug, M. V., van Oorsouw, K. I. M., Toennes, S. W., Ramaekers, J. G., & Kuypers, K. P. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.721537 · Cited by 85
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 104
van Oorsouw, K., Toennes, S. W., & Ramaekers, J. G. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06046-9 · Cited by 74
“Insights, a more positive life stance and changed worldview are commonly reported outcomes after ingestion of ayahuasca (Bouso et al. 2012; González et al. 2020; Halpern et al. 2008) and may contribute to improvements in mental health symptoms.”
BackgroundRuffell, S. G. D., Netzband, N., Tsang, W., Davies, M., Inserra, A., Butler, M., Rucker, J. J. H., Tófoli, L. F., Dempster, E. L., Young, A. H., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.687615 · Cited by 74
Metadata
- Authors
- González, D., Cantillo, J., Pérez, I., Farré, M., Feilding, A., Obiols, J. E., & Bouso, J. C.
- Affiliations
- International Center for Ethnobotanical Education, Research, and Service (ES)
- Beckley Foundation (GB)
- Universitat Autònoma de Barcelona (ES)
- Corresponding author
- González, Débora
- Venue
- Psychopharmacology
- Published
- 2020-01-14
- Volume
- 237
- Issue
- 4
- Pages
- 1171-1182
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC7113212
- OpenAlex
- W2999489633
- Cited by
- 75
- References
- 57
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 15 · 2023: 11 · 2022: 11 · 2021: 14 · 2020: 3
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Psychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- Funders
- Beckley Foundation
- Topics
- Social Sciences › Psychology › Clinical Psychology › Grief, Bereavement, and Mental Health
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- ayahuasca, grief, bereavement, experiential avoidance, decentering, acceptance, mechanisms of change, psychedelic therapy, grief severity
- MeSH terms
- Adult, Aged, Beverages, Depression, Female, Follow-Up Studies, Grief, Humans, Male, Medicine, Traditional, Middle Aged, Prospective Studies, Quality of Life, Surveys and Questionnaires, Plant Leaves, Plant Stems, Banisteriopsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.